NYSE:USPH

U.S. Physical Therapy Stock Forecast, Price & News

$127.82

-2.69 (-2.06 %)

(As of 01/15/2021 12:00 AM ET)

Add

Compare

Today's Range

$127.04

Now: $127.82▼

$131.67

50-Day Range

$105.42

MA: $118.02▼

$130.51

52-Week Range

$45.13

Now: $127.82▼

$134.11

Volume65,279 shs

Average Volume62,848 shs

Market Capitalization$1.64 billion

P/E Ratio53.26

Dividend Yield0.25%

Beta1.22

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of October 9, 2020, it operated 549 outpatient physical therapy clinics in 39 states; and managed 38 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.

MarketRank^™

Overall MarketRank^™

1.36 out of 5 stars

Medical Sector

492nd out of 1,480 stocks

Health Services Industry

3rd out of 6 stocks

1.2 Analyst's Opinion

Consensus Rating
U.S. Physical Therapy has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $90.00, U.S. Physical Therapy has a forecasted downside of 29.6% from its current price of $127.82.
Amount of Analyst Coverage
U.S. Physical Therapy has received no research coverage in the past 90 days.

2.1 Community Rank

Outperform Votes
U.S. Physical Therapy has received 226 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
U.S. Physical Therapy has received 323 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
U.S. Physical Therapy has received 58.83% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote “Outperform” if you believe USPH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe USPH will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Yield
U.S. Physical Therapy has a dividend yield of 0.25%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
U.S. Physical Therapy does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of U.S. Physical Therapy is 11.35%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 12.03% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, U.S. Physical Therapy insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,320,188.00 in company stock.
Percentage Held by Insiders
Only 2.00% of the stock of U.S. Physical Therapy is held by insiders.

1.9 Earnings and Valuation

Earnings Growth
Earnings for U.S. Physical Therapy are expected to grow by 46.15% in the coming year, from $1.82 to $2.66 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of U.S. Physical Therapy is 53.26, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.28.
Price to Earnings Ratio vs. Sector
The P/E ratio of U.S. Physical Therapy is 53.26, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 37.36.
Price to Earnings Growth Ratio
U.S. Physical Therapy has a PEG Ratio of 3.86. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
U.S. Physical Therapy has a P/B Ratio of 6.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Health services

Sub-IndustryHealth Care Facilities

SectorMedical

Current SymbolNYSE:USPH

Previous Symbol

CUSIP90337L10

CIK885978

Webwww.usph.com

Phone713-297-7000

Employees3,200

Debt

Debt-to-Equity Ratio0.13

Current Ratio1.05

Quick Ratio1.05

Price-To-Earnings

Trailing P/E Ratio53.26

Forward P/E Ratio70.23

P/E Growth3.86

Sales & Book Value

Annual Sales$481.97 million

Price / Sales3.41

Cash Flow$5.47 per share

Price / Cash Flow23.36

Book Value$18.92 per share

Price / Book6.76

Profitability

EPS (Most Recent Fiscal Year)$2.82

Net Income$40.04 million

Net Margins6.64%

Return on Equity13.36%

Return on Assets5.55%

Miscellaneous

Outstanding Shares12,850,000

Market Cap$1.64 billion

Next Earnings Date2/25/2021 (Estimated)

OptionableOptionable

$127.82

-2.69 (-2.06 %)

(As of 01/15/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive USPH News and Ratings via Email

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.

U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

How has U.S. Physical Therapy's stock price been impacted by COVID-19 (Coronavirus)?

U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, USPH stock has increased by 37.1% and is now trading at $127.82.
View which stocks have been most impacted by COVID-19.

Is U.S. Physical Therapy a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" U.S. Physical Therapy stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in USPH, but not buy additional shares or sell existing shares.
View analyst ratings for U.S. Physical Therapy or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than U.S. Physical Therapy?

Wall Street analysts have given U.S. Physical Therapy a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but U.S. Physical Therapy wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for U.S. Physical Therapy.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) announced its quarterly earnings results on Thursday, November, 5th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.51 by $0.35. The firm had revenue of $108.93 million for the quarter, compared to the consensus estimate of $103.43 million. U.S. Physical Therapy had a net margin of 6.64% and a return on equity of 13.36%. U.S. Physical Therapy's quarterly revenue was down 7.1% on a year-over-year basis. During the same period last year, the company posted $0.71 EPS.
View U.S. Physical Therapy's earnings history.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy declared a quarterly dividend on Friday, February 28th. Shareholders of record on Friday, March 13th will be given a dividend of $0.32 per share on Friday, April 17th. This represents a $1.28 annualized dividend and a yield of 1.00%. The ex-dividend date is Thursday, March 12th. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.30.
View U.S. Physical Therapy's dividend history.

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy pays an annual dividend of $0.32 per share and currently has a dividend yield of 0.25%. The dividend payout ratio of U.S. Physical Therapy is 11.35%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 12.03% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.
View U.S. Physical Therapy's dividend history.

What price target have analysts set for USPH?

3 brokerages have issued twelve-month price targets for U.S. Physical Therapy's stock. Their forecasts range from $80.00 to $100.00. On average, they anticipate U.S. Physical Therapy's share price to reach $90.00 in the next twelve months. This suggests that the stock has a possible downside of 29.6%.
View analysts' price targets for U.S. Physical Therapy or view Wall Street analyst' top-rated stocks.

Who are some of U.S. Physical Therapy's key competitors?

Some companies that are related to U.S. Physical Therapy include HCA Healthcare (HCA), Alcon (ALC), Universal Health Services (UHS), Tenet Healthcare (THC), The Ensign Group (ENSG), Acadia Healthcare (ACHC), Select Medical (SEM), National HealthCare (NHC), Community Health Systems (CYH), Brookdale Senior Living (BKD), Five Star Senior Living (FVE), Capital Senior Living (CSU) and Encompass Health (EHC).
View all of USPH's competitors.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the following people:

Mr. Christopher J. Reading, Pres, CEO & Director (Age 56, Pay $1.3M)
Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 63, Pay $804.07k)
Mr. Graham D. Reeve M.B.A., P.T., Chief Operating Officer of East (Age 56, Pay $793.34k)
Mr. Carey P. Hendrickson, Chief Financial Officer (Age 58)
Mr. Richard S. Binstein, Gen. Counsel & Sec.
Mr. Jon C. Bates, VP & Corp. Controller
Johnny J. Blanchard, Assistant Controller

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Boston Trust Walden Corp (2.89%), Scout Investments Inc. (0.72%) and State of Alaska Department of Revenue (0.08%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Clayton Trier, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson.
View institutional ownership trends for U.S. Physical Therapy.

Which institutional investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Graham D Reeve, Lawrance W Mcafee, and Mark J Brookner.
View insider buying and selling activity for U.S. Physical Therapy or view top insider-selling stocks.

Which institutional investors are buying U.S. Physical Therapy stock?

USPH stock was purchased by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, and Scout Investments Inc.. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin, and Regg E Swanson.
View insider buying and selling activity for U.S. Physical Therapy or or view top insider-buying stocks.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $127.82.

How big of a company is U.S. Physical Therapy?

U.S. Physical Therapy has a market capitalization of $1.64 billion and generates $481.97 million in revenue each year. The company earns $40.04 million in net income (profit) each year or $2.82 on an earnings per share basis. U.S. Physical Therapy employs 3,200 workers across the globe.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is www.usph.com.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]

This page was last updated on 1/15/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here